NCT07053631

Brief Summary

Elevated intracranial pressure (ICP) occurs when pressure inside the skull rises above normal levels, potentially leading to brain damage or herniation. Monitoring ICP is critical for managing conditions like brain tumors, traumatic brain injury, and stroke. Current ICP monitoring methods are invasive and carry risks, including infection and brain damage. For less severe cases, lumbar puncture is a safer, less invasive alternative. This study explores the potential of a non-invasive method, using venous pressure near the eye, to estimate ICP. The goal is to assess whether the results from this non-invasive approach are similar to the invasive lumbar CSF pressure measurements.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
10

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Apr 2025

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 7, 2025

Completed
15 days until next milestone

First Submitted

Initial submission to the registry

April 22, 2025

Completed
3 months until next milestone

First Posted

Study publicly available on registry

July 8, 2025

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 6, 2025

Completed
2 days until next milestone

Study Completion

Last participant's last visit for all outcomes

December 8, 2025

Completed
Last Updated

July 8, 2025

Status Verified

July 1, 2025

Enrollment Period

8 months

First QC Date

April 22, 2025

Last Update Submit

July 1, 2025

Conditions

Keywords

ICPnon-invasive ICP assessment

Outcome Measures

Primary Outcomes (2)

  • Venous occlusion pressure measurement (mmHg)

    Mean venous occlusion pressure of one isolated target periorbital frontal vein of 6 consecutive measurements in mmHg (mask inflated) during routine infusion test in recumbent lateral position

    60 minutes

  • intracranial Pressure (ICP) in mmHg

    Invasive lumbar intracranial pressure measurements in mmHg (mean over a 1-minute window aligned with start of venous occlusion measurements, in mmHg) during routine infusion test in recumbent lateral position

    60 minutes

Secondary Outcomes (15)

  • Measurement of venous occlusive pressure in mmHg

    60 minutes

  • Measurement of average systolic ICP in mmHg

    60 minutes

  • Measurement of average diastolic ICP in mmHg

    60 minutes

  • Relationship of venous occlusion pressure measured in mmHg compared to average ICP-Amplitude in mmHg

    60 minutes

  • Measurement of elastance of the craniospinal system measured in ml

    60 minutes

  • +10 more secondary outcomes

Study Arms (1)

Venous occlusion pressure measurements

EXPERIMENTAL
Device: venous occlusion pressure Measurement

Interventions

non-invasive venous occlusion pressure of a targeted periorbital vein is measured in parallel to clinical standard CSF dyanmic testing including standard CSF infusiontest

Venous occlusion pressure measurements

Eligibility Criteria

Age18 Years - 95 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Medical indication to perform routine craniospinal CSF dynamic testing according to standard operative procedures
  • Aged 18-95
  • Willing and able to provide valid signed informed consent

You may not qualify if:

  • Patients with any known ongoing, or history of, abnormal CSF communication
  • Patients with any kind of prior intervention for CSF diversion
  • Patients with acute brain damage within the preceding 6 months
  • Patients with transdural surgery within the preceding 6 months
  • Head wounds or hematoma that could hinder access to measurement site
  • Any known pathological condition linked to the orbital socket influencing venous outflow

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Klinik für Neurochirurgie, Universitätsklinikum Freiburg

Freiburg im Breisgau, Germany

RECRUITING

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
BASIC SCIENCE
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Funktionsoberärztin Leiterin der Liquorzirkulations-Ambulanz Fachärztin für Neurologie

Study Record Dates

First Submitted

April 22, 2025

First Posted

July 8, 2025

Study Start

April 7, 2025

Primary Completion

December 6, 2025

Study Completion

December 8, 2025

Last Updated

July 8, 2025

Record last verified: 2025-07

Data Sharing

IPD Sharing
Will not share

Locations